Michael G. Combs - 06 Jan 2025 Form 4 Insider Report for CORVEL CORP (CRVL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jan 2025, 18:25:01 UTC
Prior SEC filing
13 Nov 2024
Next SEC filing
16 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Sharon O'Connor For: Michael Combs

Key filing fact

Michael G. Combs filed Form 4 for CORVEL CORP (CRVL) on 08 Jan 2025.

Key facts

  • This page summarizes Michael G. Combs's Form 4 filing for CORVEL CORP (CRVL).
  • 12 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 08 Jan 2025, 18:25.

Change

  • Previous filing in this sequence was filed on 13 Nov 2024.
  • Current net transaction value: -$1,904,580.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL transaction

Common Stock

Options Exercise

Transaction value
$219,009
Shares
+5,499
Change %
+13%
Price
$39.83
Shares after
46,440
Date
06 Jan 2025
Ownership
Direct
CRVL transaction

Common Stock

Tax liability

Transaction value
$218,932
Shares
-2,008
Change %
-4.3%
Price
$109.03
Shares after
44,432
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
CRVL transaction

Common Stock

Tax liability

Transaction value
$140,213
Shares
-1,286
Change %
-2.9%
Price
$109.03
Shares after
43,146
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
CRVL transaction

Common Stock

Options Exercise

Transaction value
$252,905
Shares
+7,344
Change %
+17%
Price
$34.44
Shares after
50,490
Date
06 Jan 2025
Ownership
Direct
CRVL transaction

Common Stock

Tax liability

Transaction value
$252,841
Shares
-2,319
Change %
-4.6%
Price
$109.03
Shares after
48,171
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
CRVL transaction

Common Stock

Tax liability

Transaction value
$190,257
Shares
-1,745
Change %
-3.6%
Price
$109.03
Shares after
46,426
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
CRVL transaction

Common Stock

Options Exercise

Transaction value
$21,076
Shares
+1,200
Change %
+2.6%
Price
$17.56
Shares after
47,626
Date
06 Jan 2025
Ownership
Direct
CRVL transaction

Common Stock

Tax liability

Transaction value
$21,043
Shares
-193
Change %
-0.41%
Price
$109.03
Shares after
47,433
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1
CRVL transaction

Common Stock

Tax liability

Transaction value
$43,176
Shares
-396
Change %
-0.83%
Price
$109.03
Shares after
47,037
Date
06 Jan 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$130,836
Shares
-1,200
Change %
-100%
Price
$109.03
Shares after
0
Date
06 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,200
Exercise price
$17.56
Footnotes
F2
CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$800,716
Shares
-7,344
Change %
-98%
Price
$109.03
Shares after
156
Date
06 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,344
Exercise price
$34.44
Footnotes
F2
CRVL transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$599,556
Shares
-5,499
Change %
-92%
Price
$109.03
Shares after
501
Date
06 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,499
Exercise price
$39.83
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise.

Footnote F2

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .